At a glance
- What the study gets you
- Health checks and monitoring — no treatment given
- Type of study
- Observational (no treatment given)
- Time in hospital
- In-person visits at study sites — visit count not specified by the sponsor
- Drug or intervention
- Histolog Scanner (device)
- How long the study runs
- Study runs about 121 months (dates as stated)
- About the drug or intervention
- Histolog Scanner — device: Histolog Scanner intended to allow imaging of the internal microstructure of tissues including, but not limited to, the identification of cells, vessels and their organization or architecture.
- Patient visit burden
- Not specified by the sponsor
- Type of study
- Observing health over time
- Ages
- 18 Years and over
- Who
- All
- Number of participants
- 5,000
- Started
- 2026-03-04
- Last checked
- 2026-03
Plain English Summary
What is this study?
- • Testing a new treatment for adult patients undergoing a surgery or a medical procedure with use of histolog® scanner
- • Clinical study - 5,000 participants
- • The goal of this observational study is to gather real-world evidence on the performance and safety of the Histolog® Scanner (HLS) when used as intended
Who can take part?
- • Ages 18 Years and over
- • Diagnosed with adult patients undergoing a surgery or a medical procedure with use of histolog® scanner
Where?
- • Guildford - Royal Surrey County Hospital NHS Foundation Trust
This is a simplified summary. Always discuss with your doctor before making any decisions.
About This Trial
The goal of this observational study is to gather real-world evidence on the performance and safety of the Histolog® Scanner (HLS) when used as intended. HLS is a real-time ex-vivo tissue imaging device.
Adult Patients Undergoing a Surgery or a Medical Procedure With Use of Histolog® ScannerWhatever the Disease Area
How this trial compares with your answers
Answer 2 more questions to improve match
What we know so far
Condition· Matched your search
Age· Tell us your age for better matching
Gender· Tell us your sex for better matching
Still need:
- • Tell us your age for better matching
- • Tell us your sex for better matching
Preliminary match based on your answers. Full eligibility requires on-site assessment including medical history, physical exam, and lab tests. This does not guarantee enrolment.
Eligibility at a Glance
Key info
- Age: 18 Years and over
- Who can join: All genders
What the study is looking for
- ✓Age ≥18 years old at the time of consenting
- ✓Undergoing a surgery or a medical procedure with use of Histolog® Scanner
- ✓Ability to understand and the willingness to sign a written agreement to take part.
Who cannot take part
- ✗Active participation in a drug, device, or other medical intervention study that has not reached its primary...
- ✗Patients under judicial protection, legal guardianship or curatorship.
See the full criteria
Inclusion Criteria:
* Age ≥18 years old at the time of consenting
* Undergoing a surgery or a medical procedure with use of Histolog® Scanner
* Ability to understand and the willingness to sign a written informed consent.
Exclusion Criteria:
* Active participation in a drug, device, or other medical intervention study that has not reached its primary endpoint at the time of consenting
* Patients under judicial protection, legal guardianship or curatorship.
Where Is This Study? (1 UK site)
Royal Surrey County Hospital NHS Foundation Trust
Guildford GU2 7XX, United Kingdom
Site contact (verified)
Wissam Abou-ChedidPrincipal Investigator
Data sourced from ClinicalTrials.gov · Last verified: 2026-03